Even with the election over, healthcare remains in the spotlight. The Supreme Court’s decision regarding the legality of the Affordable Care Act is the next act, to be followed by action on drug pricing, surprise medical billing, and more broadly, action to lower the cost of care.
As our Numerof 2021 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about continuing to adapt to pressures on price and demands for value. You’ll continue to engage in new and different ways with healthcare delivery, physicians, regulators, public and private payers, consumers,…
As our Numerof 2021 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value while also addressing new challenges presented by the pandemic. This will create the need for changes in current roles and external…
As our Numerof 2021 US Health Insurance Outlook infographic illustrates, this year’s story for health insurance will be about dramatically changing roles and relationships. You’ll engage in new and different ways with providers, consumers, employers, regulators, medical device makers and pharmaceutical manufacturers. All this will come in the context of…
Covid-19 led to a surge in the use of telehealth across the U.S. But what’s likely to happen next? Will we see long-term impact on healthcare business models, health outcomes, and consumer expectations about healthcare convenience and access? To understand how industry leaders are thinking about telehealth in light of…
Population health management has become a national topic of conversation, but to date little effort has been devoted to tracking the actual progress that’s been made toward this new model of care. Now in its fifth year, Numerof’s State of Population Health survey provides an in-depth, national look at the…
